Edgar Filing: Raptor Pharmaceutical Corp

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Hyperion Trading Segregated Portfolio

2. Issuer Name and Ticker or Trading Symbol
Raptor Pharmaceutical Corp [RPTP]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

C/O TMF LTD. GRAND PAVILLION COMM. CTR, 2ND FL., 802 WEST BAY ROAD, PO BOX 10338

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2013

(Street)

GRAND CAYMAN, E9 KY1-1003

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/02/2013		P		11,500	A	$ 5.89 ⁽³⁾	6,454,185	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/02/2013		S		7,182	D	$ 5.98 ⁽⁴⁾	6,447,003	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/03/2013		S		5,568	D	$ 6.06 ⁽⁵⁾	6,441,435	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/04/2013		S		4,700	D	$ 6.1 ⁽⁶⁾	6,436,735	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/07/2013		S		1,800	D	$ 6.26	6,434,935	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/07/2013		P		21,800	A	$ 6.16 ⁽⁷⁾	6,456,735	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/08/2013		P		23,977	A	$ 6.19 ⁽⁸⁾	6,480,712	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/09/2013		P		56,352	A	$ 6.13 ⁽⁹⁾	6,537,064	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/16/2013		S		4,400	D	$ 5.91 ⁽¹⁰⁾	6,532,664	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/16/2013		P		2,000	A	$ 5.75 ⁽¹¹⁾	6,534,664	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/17/2013		P		7,000	A	$ 5.75 ⁽¹²⁾	6,541,664	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/22/2013		P		3,000	A	$ 5.7 ⁽¹³⁾	6,544,664	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/28/2013		P		24,500	A	$ 5.45 ⁽¹⁴⁾	6,569,164	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/29/2013		P		98,818	A	$ 5.42 ⁽¹⁵⁾	6,667,982	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	01/30/2013		P		69,455	A	$ 5.41 ⁽¹⁶⁾	6,737,437	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	02/01/2013		P		59,910	A	$ 5.49 ⁽¹⁷⁾	6,797,347	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	02/05/2013		P		26,000	A	$ 5.42 ⁽¹⁸⁾	6,823,347	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	02/08/2013		P		97,500	A	$ 5.18 ⁽¹⁹⁾	6,920,847	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	02/25/2013		S		5,250	D	$ 5.25 ⁽²⁰⁾	6,915,597	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	03/08/2013		S		1,750	D	$ 5.34	6,913,847	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	03/11/2013		S		10,000	D	$ 5.47 ⁽²¹⁾	6,903,847	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	03/15/2013		S		4,300	D	$ 5.98 ⁽²²⁾	6,899,547	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	03/22/2013		S		47,777	D	$ 5.6 ⁽²³⁾	6,851,770	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	03/26/2013		S		50,678	D	$ 5.65 ⁽²⁴⁾	6,801,092	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	03/27/2013		S		19,160	D	$ 5.71 ⁽²⁵⁾	6,781,932	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	04/04/2013		S		9,746	D	$ 6 ⁽²⁶⁾	6,772,186	D
Common Stock, par value $0.001 per share ⁽¹⁾ ⁽²⁾	04/05/2013		S		71,650	D	$ 5.95 ⁽²⁷⁾	6,700,536	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Hyperion Trading Segregated Portfolio C/O TMF LTD. GRAND PAVILLION COMM. CTR 2ND FL., 802 WEST BAY ROAD, PO BOX 10338 GRAND CAYMAN, E9 KY1-1003		X

Signatures

/s/ David P.M. Blair and Richard A. Reinert		08/19/2014
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The shares of common stock, $0.001 par value per share (the "Common Shares"), of Raptor Pharmaceutical Corp., a Delaware corporation (the "Company"), reported herein were held by Hyperion Trading Segregated Portfolio (the "Reporting Person"), a segregated portfolio of Strategic Investment Tribes Fund SPC, a Cayman Islands exempted company registered as a segregated portfolio company, managed by Sequoia Asset Management S.A., a company organized under the laws of Switzerland ("Sequoia").
(2)	The Common Shares reported herein represent transactions undertaken by the Reporting Person. Pursuant to Reg. Section 240.16a-1(a)(1), Sequoia, as the investment manager of the Reporting Person, is not deemed a beneficial owner of the Common Shares held by the Reporting Person or any other account managed by Sequoia. In the event that Sequoia is deemed a beneficial owner of the Common Shares held by the Reporting Person or any other account managed by Sequoia, pursuant to Reg. Section 240.16a-1(a)(2), its beneficial ownership is limited to its pecuniary interest, if any, in such Common Shares.
(3)	This price represents the weighted average purchase price of the Common Shares on January 2, 2013, which were purchased in multiple transactions ranging from $5.87 to $5.93, inclusive.
(4)	This price represents the weighted average sale price of the Common Shares on January 2, 2013, which were sold in multiple transactions ranging from $5.95 to $5.99, inclusive.
(5)	This price represents the weighted average sale price of the Common Shares on January 3, 2013, which were sold in multiple transactions ranging from $6.06 to $6.06, inclusive.
(6)	This price represents the weighted average sale price of the Common Shares on January 4, 2013, which were sold in multiple transactions ranging from $6.07 to $6.15, inclusive.
(7)	This price represents the weighted average purchase price of the Common Shares on January 7, 2013, which were purchased in multiple transactions ranging from $6.15 to $6.17, inclusive.
(8)	This price represents the weighted average purchase price of the Common Shares on January 8, 2013, which were purchased in multiple transactions ranging from $6.16 to $6.24, inclusive.
(9)	This price represents the weighted average purchase price of the Common Shares on January 9, 2013, which were purchased in multiple transactions ranging from $6.08 to $6.21, inclusive.
(10)	This price represents the weighted average sale price of the Common Shares on January 16, 2013, which were sold in multiple transactions ranging from $5.90 to $5.93, inclusive.
(11)	This price represents the weighted average purchase price of the Common Shares on January 16, 2013, which were purchased in multiple transactions ranging from $5.75 to $5.76, inclusive.
(12)	This price represents the weighted average purchase price of the Common Shares on January 17, 2013, which were purchased in multiple transactions ranging from $5.74 to $5.75, inclusive.
(13)	This price represents the weighted average purchase price of the Common Shares on January 22, 2013, which were purchased in multiple transactions ranging from $5.69 to $5.70, inclusive.
(14)	This price represents the weighted average purchase price of the Common Shares on January 28, 2013, which were purchased in multiple transactions ranging from $5.42 to $5.47, inclusive.
(15)	This price represents the weighted average purchase price of the Common Shares on January 29, 2013, which were purchased in multiple transactions ranging from $5.38 to $5.46, inclusive.
(16)	This price represents the weighted average purchase price of the Common Shares on January 30, 2013, which were purchased in multiple transactions ranging from $5.37 to $5.42, inclusive.
(17)	This price represents the weighted average purchase price of the Common Shares on February 1, 2013, which were purchased in multiple transactions ranging from $5.45 to $5.50, inclusive.
(18)	This price represents the weighted average purchase price of the Common Shares on February 5, 2013, which were purchased in multiple transactions ranging from $5.38 to $5.49, inclusive.
(19)	This price represents the weighted average purchase price of the Common Shares on February 8, 2013, which were purchased in multiple transactions ranging from $5.16 to $5.21, inclusive.
(20)	This price represents the weighted average sale of the Common Shares on February 25, 2013, which were sold in multiple transactions ranging from $5.20 to $5.29, inclusive.
(21)	This price represents the weighted average sale of the Common Shares on March 11, 2013, which were sold in multiple transactions ranging from $5.39 to $5.50, inclusive.
(22)	This price represents the weighted average sale of the Common Shares on March 15, 2013, which were sold in multiple transactions ranging from $5.96 to $5.99, inclusive.
(23)	This price represents the weighted average sale of the Common Shares on March 22, 2013, which were sold in multiple transactions ranging from $5.53 to $5.75, inclusive.
(24)	This price represents the weighted average sale of the Common Shares on March 26, 2013, which were sold in multiple transactions ranging from $5.58 to $5.70, inclusive.
(25)	This price represents the weighted average sale of the Common Shares on March 27, 2013, which were sold in multiple transactions ranging from $5.70 to $5.72, inclusive.
(26)	This price represents the weighted average sale of the Common Shares on April 4, 2013, which were sold in multiple transactions ranging from $5.98 to $6.04, inclusive.
(27)	This price represents the weighted average sale of the Common Shares on April 5, 2013, which were sold in multiple transactions ranging from $5.90 to $6.08, inclusive.
Remarks: 1. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the Staff of the Securities and Exchange Commission, upon request, the full information regarding the number of Common Shares bought at each separate price within the ranges set forth in this Form 4.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.